Daiichi Sankyo launches Datroway in Japan for patients with previously treated unresectable or recurrent HR positive, HER2 negative breast cancer: Tokyo Thursday, March 20, 2025, ...

Oxford BioTherapeutics (OBT) has lined up another big pharma partner for its drug discovery platform, agreeing to work with ...

The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.

IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to ...

A recent study published in Nature reveals that a Chinese research team has created an artificial intelligence tool capable ...

Puxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed ...

Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...

Intermountain Health is making it easier than ever to access medical care with the expansion of its on-demand health care ...

A Chinese research team has developed an AI tool that predicts liver cancer recurrence risk with 82.2 percent accuracy, according to a study recently published in the journal Nature.

A Chinese research team has developed an AI tool that predicts liver cancer recurrence risk with 82.2 percent accuracy, ...

Breast cancer is the most prevalent in Nigeria with over 32,000 cases yearly. Half of the women diagnosed with breast cancer ...

“Platinum-resistant ovarian cancer is one of the most challenging types of ovarian cancer to treat ... our estimate of how many PROC patients overexpress Cyclin E1 based on our proprietary ...